Charlotte Fribert

Company: Toleranzia AB
Job title: Chief Executive Officer
Seminars:
TOL2 and TOL3: Antigen Specific Tolerogenic Therapies for the Treatment of Myasthenia Gravis and ANCA vasculitis 1:00 pm
day: Day Two
Company: Toleranzia AB
Job title: Chief Executive Officer
day: Day Two